BRCA1 promoter methylation in peripheral blood is associated with the risk of triple‐negative breast cancer

The spectrum of mutations predisposing to familial breast cancer in Poland

(2019) Cezary Cybulski et al.   INTERNATIONAL JOURNAL OF CANCER

Germline promoter hypermethylation in BRCA1 and BRCA2 genes is not present in hereditary breast cancer patients

(2018) M. Rodríguez-Balada et al.   Clinical & Translational Oncology

Impact of germline and somatic BRCA1/2 mutations: tumor spectrum and detection platforms

(2017) H Wu et al.   GENE THERAPY

Levels of DNA Methylation Vary at CpG Sites across the BRCA1 Promoter, and Differ According to Triple Negative and “BRCA-Like” Status, in Both Blood and Tumour DNA

(2016) Sarah L. Daniels et al.   PLoS One

Prevalence of BRCA1 and BRCA2 germline mutations in patients with triple-negative breast cancer

(2015) Michelle W. Wong-Brown et al.   BREAST CANCER RESEARCH AND TREATMENT

Epigenome-wide association study reveals decreased average methylation levels years before breast cancer diagnosis

(2015) Karin van Veldhoven et al.   Clinical Epigenetics

Promoter Hypermethylation in White Blood Cell DNA and Breast Cancer Risk

(2015) Yoon Hee Cho et al.   Journal of Cancer

Worse Breast Cancer Prognosis of BRCA1/BRCA2 Mutation Carriers: What's the Evidence? A Systematic Review with Meta-Analysis

(2015) Alexandra J. van den Broek et al.   PLoS One

Epigenome-wide methylation in DNA from peripheral blood as a marker of risk for breast cancer

(2014) Gianluca Severi et al.   BREAST CANCER RESEARCH AND TREATMENT

Methylation of the BRCA1 promoter in peripheral blood DNA is associated with triple-negative and medullary breast cancer

(2014) Satish Gupta et al.   BREAST CANCER RESEARCH AND TREATMENT

Recurrent mutations of BRCA1 and BRCA2 in Poland: an update

(2014) M. Szwiec et al.   CLINICAL GENETICS

Triple-negative breast cancer: BRCAness and concordance of clinical features with BRCA1-mutation carriers

(2013) E H Lips et al.   BRITISH JOURNAL OF CANCER

Ten-Year Survival in Patients With BRCA1-Negative and BRCA1-Positive Breast Cancer

(2013) Tomasz Huzarski et al.   JOURNAL OF CLINICAL ONCOLOGY

BRCA1 promoter methylation in peripheral blood DNA was identified in sporadic breast cancer and controls

(2012) Rémy Bosviel et al.   Cancer Epidemiology

Pathology of Breast and Ovarian Cancers among BRCA1 and BRCA2 Mutation Carriers: Results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA)

(2012) N. Mavaddat et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

STRUCTURE-FUNCTION OF THE TUMOR SUPPRESSOR BRCA1

(2012) Serena L. Clark et al.   Computational and Structural Biotechnology Journal

Methylation of cancer related genes in tumor and peripheral blood DNA from the same breast cancer patient as two independent events

(2011) Tomasz K Wojdacz et al.   Diagnostic Pathology

No difference in the frequency of locus-specific methylation in the peripheral blood DNA of women diagnosed with breast cancer and age-matched controls

(2011) Tomasz K Wojdacz et al.   Future Oncology

BRCA1 promoter methylation in peripheral blood cells is associated with increased risk of breast cancer with BRCA1 promoter methylation

(2010) Takashi Iwamoto et al.   BREAST CANCER RESEARCH AND TREATMENT

Constitutional Methylation of the BRCA1 Promoter Is Specifically Associated with BRCA1 Mutation-Associated Pathology in Early-Onset Breast Cancer

(2010) E. M. Wong et al.   Cancer Prevention Research

Limitations and advantages of MS-HRM and bisulfite sequencing for single locus methylation studies

(2010) Tomasz K Wojdacz et al.   EXPERT REVIEW OF MOLECULAR DIAGNOSTICS

Gene-body hypermethylation of ATM in peripheral blood DNA of bilateral breast cancer patients

(2009) James M. Flanagan et al.   HUMAN MOLECULAR GENETICS

Methylation-sensitive high-resolution melting

(2009) Tomasz K Wojdacz et al.   Nature Protocols

Promoter methylation patterns of ATM, ATR, BRCA1, BRCA2 and P53 as putative cancer risk modifiers in Jewish BRCA1/BRCA2 mutation carriers

(2008) Tair Kontorovich et al.   BREAST CANCER RESEARCH AND TREATMENT